The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Cardiac Autoimmunity: Myocarditis
Open accessAbstract
Myocarditis is the inflammation of the muscle tissues of the heart (myocardium). After a pathologic cardiac-specific inflammatory process, it may progress to chronic damage and dilated cardiomyopathy. The latter is characterized by systolic dysfunction, whose clinical correlate is heart failure. Nevertheless, other acute complications may arise as consequence of tissue damage and electrophysiologic disturbances. Different etiologies are involved in triggering myocarditis. In some cases, such as giant cell myocarditis or eosinophilic necrotizing myocarditis, it is an autoimmune process. Several factors predispose the development of autoimmune myocarditis such as systemic/local primary autoimmunity, viral infection, HLA and gender bias, exposure of cryptic antigens, mimicry, and deficient thymic training/Treg induction. Once the anti-myocardium autoimmune process is triggered, several components of the immune response orchestrate a sustained attack toward myocardial tissues with particular timing and immunopathogenic features. Innate response mediated by monocytes/macrophages, neutrophils, and eosinophils parallels the adaptive response, playing a final effector role and not only a priming function. Stromal cells like fibroblast are also involved in the process through specific cytokines. Furthermore, adaptive T cell responses have anti-paradigmatic features, as Th17 response is dispensable for acute myocarditis but is the main driver of the process leading to dilated cardiomyopathy. Humoral response, thought to be a bystander, is important in the appearance of late-stage hemodynamic complications. The complexity of that process, as well as the unspecific and variable clinical presentation, had generated difficulties for diagnosis and treatment, which remain suboptimal. In this chapter, we will discuss the most relevant immunopathogenic findings from a basic science and clinical perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Su, Z., Zhang, P., Yu, Y., Lu, H., Liu, Y., Ni, P., Su, X., Wang, D., Liu, Y., Wang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep21884 · Cited by 83
RetractedJ Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,824
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,691
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children
Towbin, J. A., Lowe, A. M., Colan, S. D., Sleeper, L. A., Orav, E. J., Clunie, S. K., Messere, J. E., Cox, G. F., Lurie, P. R., Hsu, D. T., et al. (2006) · JAMA · doi:10.1001/jama.296.15.1867 · Cited by 1,055
Feldman, A. M., & McNamara, D. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 954
Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., Klingel, K., Kandolf, R., Sechtem, U., Cooper, L. T., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.074 · Cited by 919
Cited by
Sorted by citations
Items 201–228 of 228
Potential Autoimmunity of SARS CoV-2 Nucleic Acid-based Vaccination: What Should We Know?Preprint
Kelleni, M. T. (2021) · doi:10.31219/osf.io/3k4bd
Beetler, D. J., Bruno, K. A., & Fairweather, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824466-1.00014-5
Predicting Risk of Emerging Cardiotoxicity
Goins, M., Lovell, K. K., Keel, G., Cook, J. L., & Lust, R. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105040
Association of Heart Inflammation after Covid 19 Vaccination: The Systematic Review and Metaanalysis
Utami, A. T. (2022) · Journal of Clinical and Medical Images Case Reports · doi:10.55920/2771-019x/1170
Rücklová, K., David, J., Koubský, K., Pavlíček, J., Klásková, E., Šedivý, V., Krupičková, S., Malcová, H., Komínová, J., Vít, P., et al. (2023) · Cor et Vasa · doi:10.33678/cor.2022.096
Myocarditis and cardiomyopathy
Pavlíček, J., Rücklová, K., & David, J. (2023) · Česko-slovenská pediatrie · doi:10.55095/cspediatrie2023/016
Immunologic Mechanisms ofAtherosclerosis and Myocarditis
Libby, P., & Lichtman, A. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00069-1
Bahrani, Z. A., Sarawi, A. A., Shanab, H. A., Soliman, A. F., & Qarni, A. A. A. (2023) · Asian Journal of Medicine and Health · doi:10.9734/ajmah/2023/v21i9856
Myocarditis With Cardiogenic Shock In A Young Female With Severe Ulcerative Colitis Flare
Alyacoub, R., Khandait, H. V., Fichadiya, H. A., & Joshi, M. (2023) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.55729/2000-9666.1209
Myocarditis as a cause of neonate’s circulatory failure during delivery - case study
PĘKAŁA, M., Stencel, K., Berner, A., OLSZEWSKA, A., Stelmaszak, K., Polak, P., POLASZEK, M., Bogowska, M., MATYJA, K., & MARCZYK, K. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.19.01.018
Lee, H. J., & Kim, I. (2023) · Korean Circulation Journal · doi:10.4070/kcj.2023.0289
Depta, F., Olejárová, I., Rybár, D., Murín, P., Švajdler, M., & Grendel, T. (2024) · Texas Heart Institute Journal · doi:10.14503/thij-24-8431
Milinčić, K. M., Kovačević, M. M., Dulovic, D., & Ljujić, B. (2025) · EABR. Experimental and Applied Biomedical Research · doi:10.2478/eabr-2024-0060
Li, Y., He, S., Wu, J., Liu, S., Liu, R., Du, Y., Han, D., Luo, W., Huang, Z., & Yang, P. (2025) · European Journal of Inflammation · doi:10.1177/1721727x251327539
Dilated cardiomyopathy - guidelines for personalization of care
Spinelli, A., Marino, G., Macchiusi, A., Fusco, S. A. D., Pignalberi, C., & Colivicchi, F. (2025) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2025.3173
Metabolic Task Analysis Reveals Distinct Metabotypes in End-Stage Dilated Cardiomyopathy
Nihant, B., Verdonschot, J. A. J., Balăn, S., Thielecke, E., Luiken, J. J. F. P., Nabben, M., Heymans, S. R. B., Breuer, M., & Adriaens, M. E. (2026) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005366
The paradox of MTHFD2 activity in cardiac inflammation
Longhi, M. P., & Marelli‐Berg, F. M. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf251
Lu, Y., Wu, Y.-W., Pu, J., Wu, Q.-F., Dong, Q., Zhao, N., Li, G., & Du, Y.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26719710
Yimin, X., Chen, M., Chen, Q., Huang, T., Fan, Q., Fenghui, L., Ke, J., & Chen, F. (2021) · Figshare · doi:10.6084/m9.figshare.17010228
Moiseeva, O. M., Myachikova, V. Y., & Maslyansky, A. L. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6437
Gioacchino, M. D., Bagnasco, D., Braido, F., Buta, F., Caponnetto, P., Carbone, R. G., Cazzola, M., van de Veen, W., Vitis, C. D., Deng, L., et al. (2026) · Exploration of Asthma & Allergy · doi:10.37349/eaa.2026.1009111
Gretteau, P.-A. (2018) · theses.fr (ABES) · doi:10.70675/f4be6f18z80a8z47fcza5bfz0d10a6f6473c
Callon, D. (2023) · theses.fr (ABES) · doi:10.70675/e6901139zdba3z455bz9899z0821c7851b2e
Liu, L., Wu, H., Wang, Y., Huang, Z., Li, X., & Zhu, Q. (2026) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70127
Miao, Q., Zhao, W., Lyu, Z., Huang, H., Chen, Y., Chen, Y., Wei, C., Wen, Z., & Qi, H. (2026) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.250488
Myocardial inflammation in myocarditis: mechanisms and therapeutic targets
Madaudo, C., Lisi, D. D., Macaione, F., Nuzzi, V., Micarelli, A., Sausa, G., Castelli, G., Corrado, E., Galassi, A. R., & Novo, G. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1821475
Shen, W., Chen, W. F., Sun, Y., Huang, M., Zhao, J., Gao, J., Xu, W., Xu, C., Zhao, L., & Li, M. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118282
Cardioprotective Effect of Metformin Treatment in Mouse Model of Experimental Autoimmune Myocarditis
Czepiec, M., Fryt, K., Jaźwa, A., Laimbacher, A., Kania, G., Siedlar, M., Tyszka‐Czochara, M., & Błyszczuk, P. (2026) · Cardiovascular Therapeutics · doi:10.1155/cdr/6615227
Metadata
- Authors
- Bracamonte-Baran, W., & Čiháková, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Čiháková, Daniela
- ORCID
- Čiháková, Daniela
- Venue
- Advances in Experimental Medicine and Biology
- Publisher
- Springer International Publishing
- Published
- 2017
- Volume
- 1003
- Pages
- 187-221
- ISSN
- 0065-2598 (ISSN-L)
- 2214-8019
- PMC
- PMC5706653
- OpenAlex
- W2727000909
- Cited by
- 228
- References
- 167
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 28 · 2023: 43 · 2022: 32 · 2021: 41 · 2020: 22 · 2019: 12 · 2018: 11 · 2017: 1
- FWCI
- 73.98
- Type
- book chapter
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Advances in experimental medicine and biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL113008, R01HL118183)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- autoimmune myocarditis, dilated cardiomyopathy, giant cell myocarditis, Th17 response, Treg induction, HLA, viral infection, antigen mimicry, innate immune response, humoral immune response, heart failure, immunopathogenesis
- MeSH terms
- Animals, Autoimmune Diseases, Disease Models, Animal, Humans, Immunosuppressive Agents, Myocarditis, Myocardium, Prognosis, Risk Factors, Signal Transduction, Autoimmunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review